Influence of time between surgery and postoperative radiation therapy and total treatment time in locoregional control of patients with head and neck cancer: a single center experience (2020)
- Authors:
- Autor USP: CASTRO JUNIOR, GILBERTO DE - FM
- Unidade: FM
- DOI: 10.6061/clinics/2020/e1615
- Subjects: NEOPLASIAS DE CABEÇA E PESCOÇO; PERÍODO PÓS-OPERATÓRIO; ESTUDOS RETROSPECTIVOS; TAXA DE SOBREVIVÊNCIA
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
FRANCO, Rejane et al. Influence of time between surgery and postoperative radiation therapy and total treatment time in locoregional control of patients with head and neck cancer: a single center experience. Clinics, v. 75, 2020Tradução . . Disponível em: https://doi.org/10.6061/clinics/2020/e1615. Acesso em: 23 jan. 2026. -
APA
Franco, R., Matos, L. L. de, Kulcsar, M. A. V., Castro Junior, G. de, & Marta, G. N. (2020). Influence of time between surgery and postoperative radiation therapy and total treatment time in locoregional control of patients with head and neck cancer: a single center experience. Clinics, 75. doi:10.6061/clinics/2020/e1615 -
NLM
Franco R, Matos LL de, Kulcsar MAV, Castro Junior G de, Marta GN. Influence of time between surgery and postoperative radiation therapy and total treatment time in locoregional control of patients with head and neck cancer: a single center experience [Internet]. Clinics. 2020 ; 75[citado 2026 jan. 23 ] Available from: https://doi.org/10.6061/clinics/2020/e1615 -
Vancouver
Franco R, Matos LL de, Kulcsar MAV, Castro Junior G de, Marta GN. Influence of time between surgery and postoperative radiation therapy and total treatment time in locoregional control of patients with head and neck cancer: a single center experience [Internet]. Clinics. 2020 ; 75[citado 2026 jan. 23 ] Available from: https://doi.org/10.6061/clinics/2020/e1615 - Young head and neck cancer patients are at increased risk of developing oral mucositis and trismus
- The role of single-nucleotide polymorphism (SNPs) in toxicity of induction chemotherapy based on cisplatin and paclitaxel in patients with advanced head and neck cancer
- Desenvolvimento de fármacos: pesquisa clínica e medicina de precisão
- Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
- Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03)
- Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
- Manual de oncologia torácica
- Noções de oncologia torácica
- Pembrolizumab alone or with chemotherapy for recurrent/metastatic had and neck squamous cell carcinoma in KEYNOTE-048: subgroup analysis by programmed death Ligand-1 combined positive score
- Quimiorradioterapia concomitante em pacientes portadores de carcinoma espinocelular de cabeça e pescoço não elegíveis para tratamento cirúrgico
Informações sobre o DOI: 10.6061/clinics/2020/e1615 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
